Pricing and Order Playbooks
Two paths are available: build protocol and amendment playbooks yourself in SCOPE for free, or have a ClinScreen specialist build them for you through Order Playbooks.
Build it yourself in SCOPE
Free
Both protocol playbooks and amendment updates are free when your team builds them in SCOPE.
Protocol Playbook Credit
Free
Build and revise protocol playbooks yourself in SCOPE.
Amendment Update Credit
Free
Build and revise amendment updates yourself in SCOPE.
- • Free Mac App Store download
- • Use Build/Edit Playbook in SCOPE for free
- • Local-first pre-screening workflow on macOS
- • No paid tier gates the core workflow
Have ClinScreen build it for you
For teams that want operational handoff, a ClinScreen specialist can build the protocol or amendment playbook for the prices below.
Protocol Playbook Credit
$300
Per 1 protocol added to a bundled playbook.
Amendment Update Credit
$150
Per 1 protocol amendment added or updated.
Turnaround target: 5 business days after complete materials are received.
- • Protocol Playbook Credit: 1 protocol added to a bundled playbook plus one revision round.
- • Amendment Update Credit: 1 protocol amendment added or updated plus one revision round.
- • Revision requests must be submitted within 10 business days of delivery.
- • Output: playbook file plus a brief change log.
- • Decision support for pre-screening workflows.
Managed-playbook work can be budgeted as a pass-through vendor cost in sponsor budgets and contracts.
Suggested line item: “Clinical screening playbook build may qualify as a vendor cost (pass-through)”
If in-app purchases are blocked on managed devices, the app shows this neutral message:
If your managed devices has disabled in-app purchases, contact support for help.
Outside the app, support can coordinate standard invoice procurement for constrained environments.
- • Inputs: protocol PDF required, sponsor or site screening script optional, site notes optional.
- • Fulfillment is manual via email after purchase and materials receipt.
- • No guarantee of regulatory compliance.